Cholesterol Test Market Research Report Information By Product Type (Test Kits and Test Strips), By Test Type (Total Cholesterol Test, High-Density Lipoprotein (HDL) Cholesterol, Low-Density Lipoprotein (LDL) and Cholesterol and Triglycerides/VLDL Cholesterol Test), By Distribution Channel (Over the Counter, and Prescription Based), By End-User (Hospitals & Clinics, Homecare and Diagnostic Centers), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030.

Global Cholesterol Test Market Overview

Cholesterol Test Market Size was valued at USD 6.2 billion in 2022. The Cholesterol Test market industry is projected to grow from USD 6.7 Billion in 2023 to USD 11.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.20% during the forecast period (2023 - 2030). The growing prevalence of high cholesterol levels is expected to drive the growth. Rising awareness about a routine screening of cholesterol levels is another significant growth driver. These are just a few of the market drivers that are driving the market.

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Cholesterol Test Market Trends

• Prevalence of cardiovascular diseases and rising cases of obesity propel market growth

The prevalence of cardiovascular diseases and rising cases of obesity are significantly driving market growth. Moreover, the inelastic need is related to cardiovascular patients requiring daily monitoring of CholesterolCholesterol for effective therapeutic monitoring. The health departments of various countries stipulate that children aged 9-11 should be tested, and young adults aged 17-21 should be tested. Cholesterol testing is critical to keeping patients on track with their health, as high CholesterolCholesterol shows no symptoms. Cholesterol testing involves estimating different lipids, such as triglycerides, HDL, LDL, and total blood cholesterol. If performed effectively with proper precautions at each stage, these tests can help reduce the risk of heart attack, peripheral arterial disease, and heart disease. Thus, this factor is driving the market CAGR.

Increasing numbers of heart attacks, diabetes, kidney failure and heart attacks have affected millions worldwide. Rising R&D investments and the development of new advanced testing procedures, supported by technological advancements in healthcare infrastructure in developing countries, have increased the demand for these tests. Advances in healthcare infrastructure have facilitated a high level of efficiency in diagnostic and management procedures. Furthermore, the rising adoption of AI and IoT in healthcare helps boost the market over the forecast period. Thus, it is anticipated that this aspect will accelerate the Cholesterol Test market revenue ly.

Cholesterol Test Market Segment Insights

Cholesterol Test Product Type Insights

Based on product type, the  Cholesterol Test market segmentation includes test kits and test strips. The test kits held the majority share in 2022 in the  Cholesterol Test market data. Patients now have better access to cholesterol testing thanks to the development of cutting-edge testing kits. Due to technological advancements, cholesterol testing kits are expected to be the fastest-growing segment.

Cholesterol Test Test Type Insights

Based on test type, the  Cholesterol Test market segmentation includes total cholesterol test, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) and CholesterolCholesterol and triglycerides/VLDL cholesterol test. The total cholesterol test dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. This is attributed to an increased awareness of routine cholesterol testing and treatment and the sedentary lifestyle that contributes to the development of many diseases, including diabetes, which drives the market's growth.

Cholesterol Test Distribution Channel Insights

The  Cholesterol Test market data, based on the distribution channel, include over-the-counter and Prescription based. The target audience prefers all these distribution channels according to the consumer's requirements.

Cholesterol Test End-User Insights

Based on end-user, the  Cholesterol Test market data include hospitals & clinics, home care and diagnostic centers. The diagnostic center segment dominated the Cholesterol Test market revenue in 2022 and is projected to be the faster-growing segment during the forecast period 2022-2030. Since more and more people are being diagnosed with high total CholesterolCholesterol, the demand for the market is rising. Moreover, regular health check-ups without physician intervention are a high-impact driver for the segment's growth.

Figure 1  Cholesterol Test Market by End-User, 2022 & 2030 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Cholesterol Test Regional Insights

By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North America Cholesterol Test market accounted for USD 2.8 billion in 2022, with a share of around 45.80%, and is expected to exhibit a significant CAGR growth during the study period. Americas is the most important regional market. Countries like the US have well-developed healthcare operations. Furthermore, one of the major reasons driving the cholesterol testing market during the forecast years is the rising prevalence of stroke in the United States.

Further, the major countries studied in the market report are The U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2  CHOLESTEROL TEST MARKET SHARE BY REGION 2022 (%)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe's Cholesterol Test market accounts for the second-largest market share. Rising awareness among patients regarding preventive healthcare has increased the usage of cholesterol-testing products and services. Potential players in the market have helped increase market efficiency and production of these test kits and devices, further increasing the market opportunity. Moreover, the UK Cholesterol Test market held the largest market share, and the Germany Cholesterol Test market was the fastest-growing market in the region.

Asia Pacific Cholesterol Test Market is expected to grow at the fastest CAGR from 2022 to 2030. Asia Pacific is growing faster and more lucrative owing to the increasing population in the region. An increase in investment and expenditure in healthcare infrastructure has led to the development of diagnostic centers and pathology laboratories for better diagnosis. Further, the China Cholesterol Test market held the largest market share, and the India Cholesterol Test market was the fastest-growing market in the region.

Cholesterol Test Key Market Players & Competitive Insights

Major market players are spending a lot on R&D to increase their product lines, which will help the Cholesterol Test market grow even more. Market participants are also taking various strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, mergers and acquisitions, contractual agreements, increased investments, and collaboration with other organizations. Competitors in the Cholesterol Test industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies manufacturers adopt in the  Cholesterol Test industry to benefit clients and expand the market sector is manufacturing locally to reduce operating costs. The Cholesterol Test industry has provided medicine with some of the most significant benefits in recent years. The CholesterolCholesterol Test markets major players such as Nestle, JM Smucker Company, The Kraft Heinz Company and Starbucks Cholesterol Test Company.

Quest Diagnostics empowers people to take action to improve health outcomes. Quest's diagnostic insights, drawn from the world's largest database of clinical laboratory results, reveal new ways to identify and treat disease, inspire healthy behaviors, and improve healthcare management. In June 2022, Quest Diagnostics, the world's leading provider of diagnostic information services, announced that it would hold its 82nd. The results of six studies were presented at the American Diabetes Association Scientific Sessions in New Orleans, LA.

Also, Thermo Fisher Scientific Inc. is an American provider of scientific instruments, reagents and consumables, and software services. Thermo Fisher, headquartered in Waltham, Massachusetts, was formed in 2006 through the merger of Thermo Electron and Fisher Scientific. Thermo Fisher Scientific has acquired other reagents, consumables, instrumentation and service providers, including Life Technologies Corporation (2013), Affymetrix (2015), Affymetrix (2016), FEI Corporation (2016), BD Advanced Bioprocessing (2018), PPD (2021).

Key Companies in the Cholesterol Test market include

• Quest Diagnostics Incorporated


• Clinical Reference Laboratory Inc.


• Randox Laboratories Ltd.


• PTS DIAGNOSTICS


• Hoffmann-La Roche AG


• Cell Biolabs Inc.


• Laboratory Corporation of America Holdings


• Thermo Fisher Scientific


• Alere Inc.


• Eurofins Scientific

Cholesterol Test Industry Developments

May 2022 Goodbody Health launched its core UK Health 'MOT' test. This new Test includes innovative clinical diabetes and cholesterol tests that can confirm results in minutes. These tests determine a person's risk of developing heart health problems or diabetes over the next ten years.

March 2022 Rosalind Franklin University's (RFU) Community Nursing Connection and a new partnership with North Shore University Health System continue to provide life-saving medical care to the underserved in many North Chicago communities. Care Coach, a mobile health unit staffed by licensed healthcare professionals, will directly benefit from $680,000 in financing from the NorthShore Community Investment Fund (CIF). The mobile device provides blood pressure control, diabetes screening, BMI, cholesterol testing and other free health treatments.

Cholesterol Test Market Segmentation

Cholesterol Test Product Type Outlook (USD Billion, 2018-2030)

• Test Kits


• Test Strips

Cholesterol Test Test Type Outlook (USD Billion, 2018-2030)

• Total Cholesterol Test


• High-Density Lipoprotein (HDL) Cholesterol


• Low-Density Lipoprotein (LDL)


• Cholesterol and Triglycerides/VLDL Cholesterol Test)

Cholesterol Test Distribution Channel Outlook (USD Billion, 2018-2030)

• Over the Counter


• Prescription Based

Cholesterol Test End-User Outlook (USD Billion, 2018-2030)

• Hospitals & Clinics


• Homecare


• Diagnostic Centers

Cholesterol Test Regional Outlook (USD Billion, 2018-2030)

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • AfricaLatin America